The association of combined metabolic score for insulin resistance and frailty index with incident cardiometabolic multimorbidity.
It is suggested that a joint metabolic-frailty burden indicator provides incremental prognostic value beyond conventional risk factors and may serve as a practical composite indicator for CMM risk stratification among middle-aged and older adults.